Christopher Ong
9PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 13, 2026
PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges.Takashi Matsuoka, Shusuke Akamatsu, Christopher J Ong
|Jan 08, 2025
Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities.Ning Kang, Hui Xue, Nelson K Y Wong
|Jun 27, 2024
G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications.Yuchao Ni, Mingchen Shi, Liangliang Liu
|Oct 06, 2023
Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells.Parvin Yenki, Satyam Bhasin, Liang Liu
|Jul 14, 2023
Dependency of Tamoxifen Sensitive and Resistant ER<sup>+</sup> Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth.Satyam Bhasin, Christopher Dusek, James W Peacock
|Jan 27, 2021
SEMA3C induces androgen synthesis in prostatic stromal cells through paracrine signaling.Parvin Yenki, Hans H Adomat, Christopher J Ong
Pageof 2
Frequent Collaborators
3 joint publications
Yuzhuo Wang
2 joint publications
Martin Gleave
2 joint publications
Parvin Yenki
2 joint publications
Dong Lin
1 joint publications
Satyam Bhasin
1 joint publications
Ning Kang
1 joint publications
Hui Xue
1 joint publications
Nelson K Y Wong
1 joint publications
Yen-Yi Lin
1 joint publications
Adam Classen
